ACR 2022 Tweet by Eric Dein

Ab1042 #ACR22 Ixekizumab Long-term Safety
A Deodhar: Pooled 25 studies for PsO, PsA, AS

5.4 pooled AE per 100-patient/year
0.5 IBD per 100-PY
1.3 Oral candidiasis per 100-PY

Re-assuring safety numbers. Deodhar: "These are numbers to use in clinical practice"
@RheumNow